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Abstract
Closely related transcription factors (TFs) can bind to the same response elements (REs) with similar affinities and activate
transcription. However, it is unknown whether transcription is similarly orchestrated by different TFs bound at the same RE.
Here we have compared the recovery half time (t1/2), binding site occupancy and the resulting temporal changes in
transcription upon binding of two closely related steroid receptors, the androgen and glucocorticoid receptors (AR and GR),
to their common hormone REs (HREs). We show that there are significant differences at all of these levels between AR and
GR at the MMTV HRE when activated by their ligands. These data show that two TFs bound at the same RE can have
significantly different modes of action that can affect their responses to environmental cues.
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Introduction
The first and most critical step in regulation of gene expression
is transcription which is a highly ordered process where protein
complexes are sequentially recruited to target genes, including the
specific transcription factors (TFs), the general TFs and RNA
polymerases. Whereas the general TFs bind to well-characterized
sites in the promoter, specific TFs bind to response elements (REs)
that are either in the vicinity of or far away from the target genes.
TFs bind to their REs with high precision which is the basis for the
specificity of gene regulation in response to environmental cues
that modulate TF activity.
It is known that related TFs can bind to and regulate
transcription from the same RE. This may result in similar or
opposing activities at the same RE, leading to corresponding
transcriptional outcomes (for reviews, see [1–3]). However, the
nature of the binding events, and whether the transcriptional
program is similarly affected, is not known.
One group of TFs that can bind to and activate transcription
from the same RE is the steroid receptors that belong to the
nuclear receptor superfamily [4,5]. Despite distinct roles of
individual steroids, there are significant similarities in the REs
recognized by their receptors. For example, the consensus
hormone RE (HRE) for the glucocorticoid receptor (GR) is a
family of related sequences composed of an imperfect palindrome
of hexameric half sites separated by a 3-base pair spacer [6,7] with
some modifications identified recently in genome-wide analyses
(e.g. [8]). This HRE is also recognized by the androgen receptor
(AR), progesterone receptor (PR), and the mineralocorticoid
receptor (MR) [9,10]. These findings have raised the question as
to how the selectivity of hormone action is achieved in cells where
more than one steroid receptor is expressed and when their ligands
are concurrently available.
There are several steps at which selective effects of two TFs that
bind to the same RE can be achieved. First, recently documented
rapid TF interaction with chromatin in living cells [11] could be
different for the two TFs. Second, TFs may differentially and in a
temporally distinct manner recruit cofactors and chromatin
modifying complexes to the promoters they interact with (for
reviews, see [12,13]). Third, consequence of RE association of a
TF on the local chromatin environment can vary for different TFs.
To date, there is no thorough analysis of these different levels of
regulation to determine whether different TFs can differentially
affect them when bound at the same RE.
To compare the dynamics and activities of two closely related
TFs at all of these different levels, we have used the prototypical
and well characterized mouse mammary tumor virus (MMTV)
promoter that contains HREs for steroid receptors. Using a cell
system that has a tandem array of the MMTV promoter [14], we
studied the fluorescence recovery half time (t1/2) measured by
fluorescence recovery after photobleaching (FRAP), binding site
occupancy determined by chromatin immunoprecipitation (ChIP),
and transcription dynamics induced by AR compared with GR.
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We show that there are differences at all of these levels in response
to agonist stimulation. These data indicate that two TFs of the
same family bound at the same RE can have mechanistically
different modes of regulating transcription which helps explain the
selectivity in the activity of TFs with similar DNA binding
specificities.
Materials and Methods
Chemicals
Methyltrienolone (R1881) was purchased from Dupont-NEN,
and Dexamethasone (DEX) from Sigma. All chemicals were
dissolved in 100% ethanol and used at working concentrations of
10 nM (R1881) and 100 nM (DEX). 5,6-dichloro-1-b-D-ribofur-
anosyl- benzimidazole (DRB) (Sigma) and actinomycin D (ActD)
(Calbiochem) were dissolved in DMSO and used at working
solutions of 100 mg/ml and 1 mM, respectively.
Cell Culture
Stable cell lines expressing GFP-AR (3108) and GFP-GR (3617)
under the control of the Tet-Off inducible system were previously
described [14,15]. The cells were grown at 37uC with 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum, 2 mM L-glutamine, 5 mg/ml penicillin/
streptomycin (Life Technologies, Inc.) and 10 mg/ml tetracycline
(Sigma) (to suppress GFP-AR and GFP-GR expression). In
preparation for experiments, cells were grown in this medium
without tetracycline in order to induce expression of the receptor.
Cells were then transferred to growth medium without tetracy-
cline, containing 10% charcoal-stripped serum for 48 h to remove
steroids. Prior to imaging experiments, cells were treated as
described above, except phenol-red free medium was used to
eliminate autofluorescence.
Fluorescence Recovery After Photobleaching (FRAP)
3108 and 3617 cells were grown in MatTek plates for live cell
imaging (Nunc) and treated with the agonists R1881 or DEX
alone, or in combination with the transcription inhibitors DRB or
ActD (time course of 0.5, 1.5, 2.5 and 4 h with R1881 or 1, 4 and
8 h with DEX, or for 1.5 h for transcription inhibition). FRAP
analyses were carried out on an Olympus FluoView FV1000
confocal laser scanning microscope equipped with a PlanApo 60X
1.4 NA oil objective (Olympus, Hamburg, Germany) and a SIM
scanner. Constant temperature was set to 37uC by an incubator
enclosing the microscope stage. Five single prebleach images were
acquired followed by a brief bleach pulse of 100 msec using 405-
nm laser line at 100% laser power (laser output, 30%) without
attenuation. Single optical sections were acquired at 500 msec
intervals by using 488-nm laser line with laser power attenuated to
10%. Fluorescence intensities in the regions of interest were
analyzed, and FRAP recovery curves were generated using
Olympus FV10-ASW 1.7b software and Microsoft Excel as
previously described [16]. All of the quantitative data for FRAP
recovery kinetics were collected from 11–30 cells in total imaged
on at least two separate days.
For semi-quantitative analysis and determination of t1/2, FRAP
curve of each cell was interpolated to the same temporal sampling,
and fit with a function which is the sum of three exponentials.
From this fit, it was calculated how long it takes the curve to reach
50% of its final recovery value. For each experimental condition,
each individual FRAP curve was fit with the model. After the
extraction of the t1/2, the average t1/2 and corresponding standard
error was calculated.
Western Analysis
3108 and 3617 cells were left either untreated or treated with
R1881 or DEX for 1, 4 and 8 h before the cells were harvested by
scraping in PBS and collected by centrifugation. The cell pellet
was washed twice in ice-cold PBS. Whole cell extract was prepared
by resuspending the cells in 200 ml of lysis buffer (20 mM HEPES
pH 7.4, 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1%
Triton X-100, 0.5 mM DTT, 0.5 mM PMSF, protease inhibitor
cocktail from Sigma). The suspension was rotated at 4uC for 1 h,
followed by centrifugation at 13000 rpm for 10 min. The
supernatant was collected after centrifugation, and the protein
concentration was determined using the Bradford assay (BioRad).
The proteins were resolved on a 7% SDS PAGE gel, and
transferred to a PVDF membrane (BioRad). The membrane was
blocked in 5% skimmed milk in Tris buffered saline (TBS)-0.1%
Tween 20 and following by incubation with the primary
antibodies for GFP (Invitrogen, 1:1000) and a-tubulin (Sigma,
1:4000) in 3% BSA in TBS-0.1% Tween 20. HRP-linked
secondary antibodies (Sigma, 1:5000–10000 in 0.5% skimmed
milk in TBS-0.1% Tween 20) and an enhanced luminescence kit
(SuperSignal West Dura Chemiluminescent Substrate, Thermo
Scientific) were used for the detection of proteins. Images were
obtained on a Kodak imaging station 4000R and the band
intensities were determined using Carestream Imaging Software.
The specific Western signals were quantified using Carestream
Health imaging software. The measured intensity of GFP signals
were then normalized to the corresponding a-tubulin signal. The
Western blot images are representative of two independent
experiments.
Chromatin Immunoprecipitation Assay (ChIP)
ChIP experiments were carried out according to the standard
protocol (Upstate Biotechnology) with some modifications. 3108
and 3617 cells were treated with R1881 or DEX alone, or in
combination with the transcription inhibitors DRB or ActD (time
course of 1, 2, 4 and 8 h with R1881 or 1, 4 and 9 h with DEX, or
for 1.5 h for transcription inhibition), and crosslinked with 1%
formaldehyde at 37uC for 10 min, followed by a quenching step
with 125 mM glycine for 5 min. Cells were washed twice with ice-
cold phosphate buffered saline (PBS) containing a complete
protease inhibitor cocktail (PI; Roche Diagnostics), harvested in
PBS plus PI and pelleted by centrifugation (2000 rpm, 5 min,
4uC). After lysis in ChIP lysis buffer (50 mM Tris-HCl pH 8,
10 mM EDTA, 0.5% SDS, PI) for 1.5 h on ice, chromatin was
sonicated at high intensity for 30 min (3x 10 bursts of 30 sec ON
and 30 sec OFF; 4uC) using the Bioruptor sonicator (Diogenode).
After centrifugation (13000 rpm, 10 min, 4uC), sheared chromatin
was diluted in ChIP dilution buffer (0.01% SDS, 1% Triton X-
100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl,
PI) to 25 mg/ml, precleared with 50% slurry of protein A-agarose
beads (Millipore) (2 h, 4uC), and immunoprecipitated overnight
with an anti-GFP (Invitrogen), anti-elongating RNA polymerase II
(Pol II phosphoS2; Abcam) or non-specific rabbit IgG (Vector
Laboratories) antibody at 4uC on a rotating platform. Antibody-
bound chromatin complexes were incubated with 60 ml of protein
A-agarose beads for 1.5 h at 4uC. Antibody-chromatin-bead
complexes were then washed with each ChIP wash buffer plus
PI once for 15 min in the following order: Low salt immune
complex buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris-HCl pH 8.1, 150 mM NaCl), high salt immune
complex buffer (0.1% SDS, 1% Triton x-100, 2 mM EDTA,
20 mM Tris-HCl pH 8.1, 500 mM NaCl) LiCl immune complex
buffer (0.25 M LiCl, 1% IGEPAL-360, 1% sodium deoxycholate,
1 mM EDTA, 10 mM Tris-HCl pH 8.1) and TE (10 mM Tris-
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HCl pH 8, 1 mM EDTA), and antibody-chromatin complexes
were eluted twice in SDS buffer (first in 1% SDS, 0.1 M sodium
bicarbonate; second in 1.5% SDS, 0.1 M sodium bicarbonate).
Formaldehyde crosslinking was reversed in elution buffer (con-
taining 40 mM Tris-HCl pH 6.5, 10 mM EDTA, 200 mM NaCl,
proteinase K from Roche Diagnostics) at 65uC overnight, followed
by DNA purification using phenol-chloroform-isoamyl alcohol
mixture (Sigma-Aldrich) and ethanol precipitation. Immunopre-
cipitated DNA, as well as input DNA, was eluted in 50 ml of water
and quantified by quantitative polymerase chain reaction (qPCR)
on a LightCycler 480 instrument (Roche Diagnostics) with the
LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics)
in duplicates using primer sets specific for the MMTV-LTR Nuc-
B region. Primer sequences are available upon request. ChIP assay
was performed as duplicates of two independent experiments.
Quantitative Reverse Transcription-PCR (qRT-PCR)
3108 and 3617 cells were grown in triplicates on 6-well dishes
for 48 h, and left either untreated (CTR) or treated with R1881/
DEX, or the inhibitors DRB/ActD alone or in combination for
1.5 h (agents were added at the same time as ligands). Total RNA
was extracted with Trizol reagent (Invitrogen) according to
manufacturer’s recommendations, followed by elution using
QIAGEN RNeasy columns. RNA was then subjected to first-
strand cDNA synthesis using the SuperScript II system (Invitro-
gen). V-ras expression levels were determined by qPCR in
duplicates using the LightCycler 480 instrument (Roche) with
the LightCycler 480 SYBR Green I Master Mix (Roche). A
standard curve was created by serial dilutions of cDNA to
calculate the relative amount of Ras and Rplp0 for each sample.
These values were then normalized to the relative amount of
Rplp0. qRT-PCR results were obtained from two independent
experiments.
Results
Androgen and glucocorticoid receptors have distinct
dynamics and transcription kinetics at the same HRE
We have previously generated a cell line to study in vivo
dynamics of AR with chromatin, 3108 cells [15], based on the
model system developed for GR, 3617 cells [14]. These two mouse
mammary adenocarcinoma cell lines were generated by stable
transfection of a green fluorescent protein (GFP) tagged AR
(pTRE-Tight-GFP-AR) or GR (pTet-nGFP-C656G) construct
under tetracycline repressible promoter into the same parental cell
line (3134 cells). 3134 cells contain approximately 200 copies of a
1.3 kb MMTV-LTR sequence fused to a 600 bp fragment of
Harvey sarcoma virus encoding the v-Ras gene product as a
reporter integrated into chromosome 4 in a tandem fashion; this
enables the direct visualization of GFP tagged AR or GR binding
to the MMTV promoter in live cells. As each copy harbors
binding sites for four to six receptor molecules, the MMTV array
has a capacity for about 1000 receptor molecules. In the genome,
the MMTV promoter is characterized by a series of six positioned
nucleosomes (A-F); ligand bound AR and GR can bind to the
HREs located in the nucleosome B/C region, promoting
transcription of the Ras reporter gene [17,18]. Using these cells
and FRAP allows the measurement of highly dynamic interactions
between the receptor and the DNA template in living cells [19].
GFP-AR and GFP-GR bind to the same HREs in the MMTV
LTR and the hormone response of promoters within the MMTV
array is indistinguishable from that of a single-copy gene [20,21].
Previous experiments determined the recovery half time of
GFP-GR and GFP-AR in FRAP experiments where the region of
MMTV array appeared as a bright spot in the nucleus was
selectively photobleached and then the time at which fluorescence
enters the bleached region was measured. The fluorescence
recovery contains information about the diffusion rate of GFP-
AR and GFP-GR plus any binding interactions with large,
relatively immobile substrates [14,15,19]. However, these were
done at single time points and in different conditions for GFP-AR
and GFP-GR. To assess whether there are any changes to the
recovery half-time of the receptors during the course of the
transcription response, FRAP analysis was carried out at different
time points after hormone addition. As shown in Figure 1A, GFP-
AR expression increased slightly by 4 h after hormone addition
and decreased by 8 h, whereas GFP-GR expression was similar at
1 and 4 h which decreased by 8 h. The FRAP recovery curves for
GFP-AR or GFP-GR were similar at different time points after
hormone addition (Figures 1B and 1C). Interestingly, under these
experimental conditions and using the same equipment and
settings, the recovery half-time for GFP-AR was significantly
slower compared with that for GFP-GR (compare Figure 1B and
1C). This indicates that GFP-AR interactions with the MMTV
HREs are stronger compared with GFP-GR.
To determine the kinetics of GFP-AR-mediated transcription at
the MMTV LTR in 3108 cells, we performed a time-course
experiment and determined reporter gene Ras expression by
qPCR. As shown in Figure 2A, Ras mRNA levels continued to
increase upon R1881 addition reaching maximal levels at around
8 h which did not significantly change thereafter up to 12 h. The
Ras expression profile in response to R1881 was qualitatively
similar by RNA FISH (see Figure S1 and Method S1).
We next determined GFP-AR occupancy levels at the MMTV
promoter during the same time course using chromatin immuno-
precipitation (ChIP) which gives an average of bound molecules in
the whole cell population during the time it takes to fix the
interactions. There was a rapid increase in GFP-AR occupancy at
the MMTV HRE upon hormone activation reaching maximal
levels of ,25–30-fold higher than basal levels by 60 min and
remained essentially unchanged through the course of the
experiment up to 12 h indicating that GFP-AR mediated
transcription profile is similar to the GFP-AR occupancy at the
MMTV array (Figure 2A).
We then carried out similar experiments with GFP-GR in 3617
cells. As shown in Figure 2B, GFP-GR activation of MMTV-Ras
was significantly greater and more rapid compared with GFP-AR
reaching maximum levels by 2 h and declining rapidly thereafter,
consistent with previous findings [22]. ChIP analysis showed that
in parallel with Ras expression, GFP-GR occupancy at the
MMTV HRE increased ,35-fold by 1 h and then rapidly
declined to 50% at 2 h and to 20% at 8 h (Figure 2B). Overall,
GFP-GR mediated transcription profile followed receptor binding
profile at the MMTV array.
Transcription inhibitors differentially affect GFP-AR and
GFP-GR mobility coupled to Pol II association
In order to determine whether the differential activities of GFP-
AR and GFP-GR at the MMTV array are linked to transcription,
we used two Pol II inhibitors, 5,6-dichloro-1-b-D-ribofuranosyl-
benzimidazole (DRB) and actinomycin D (ActD). DRB, a protein
kinase inhibitor, prevents Pol II phosphorylation on Serine 2 and
productive elongation [23,24] whereas ActD intercalates to DNA
and blocks Pol II progression [25]. As shown in Figure 3A, both
agents efficiently inhibited hormone-induced transcription by both
GFP-AR and GFP-GR, as expected.
We then checked whether transcription inhibition by these
agents affects GFP-AR and GFP-GR mobility using FRAP
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analysis. We found that whereas DRB treatment did not have an
effect, ActD led to a temporarily immobilized fraction for either
receptor (Figure 3B). These data show that DRB and ActD
differentially affect mobility of GFP-AR and GFP-GR in the
nucleus.
Next we checked GFP-AR and GFP-GR occupancy at the
MMTV LTR by ChIP analysis in response to DRB and ActD. As
shown in Figure 3C, occupancy levels of both receptors at the
MMTV HREs were decreased by 20% and 30% in the presence
of DRB, whereas this decrease reached 40% and 70% with ActD
for GFP-AR and GFP-GR, respectively.
As both DRB and ActD block transcription by inhibiting
elongating Pol II, we examined Pol II-pSer2 levels at the MMTV
array after DRB and ActD treatment by ChIP. As expected, in the
presence of DRB, Pol II-pSer2 loading was decreased in both cell
lines, with a stronger effect in GFP-GR cells (Figure 3D).
Interestingly, ActD significantly decreased Pol II-pSer2 levels in
response to GFP-GR activation, but not for GFP-AR.
Altogether, these data show that there are important differences
in the way the two receptors associate with HREs. Furthermore,
these results indicate that the transcription complexes that are
assembled are differentially sensitive to DRB and ActD with
distinct consequences for the transcriptional output.
Discussion
The binding of a TF to its target RE is central to all aspects of
development and homeostasis in metazoans as well as in lower
organisms. TFs most often belong to families whose members are
typically generated by duplication events during evolution and
thus have closely related DNA binding domains and structures.
For example, in metazoans TF families include bHLH, Mef2, Fox,
Sox, ETS, Rel/Nf-kB, bZIP, Smad, and nuclear receptor proteins
that have many members and even more closely related subgroups
within each family. Whereas different mechanisms, such as
divergence in the DNA binding domain sequences and ability to
differentially heterodimerize with distinct partners, can generate
TF specificity, some members of a TF family often bind and
regulate transcription from the same REs interacting with the
same cofactors. It has thus been unknown as to whether different,
but related TFs would use similar mechanisms and activate
transcription in the same manner when bound at the same RE.
Here we have used two members of the nuclear receptor family of
TFs, AR and GR, and a common HRE that they bind to and
activate transcription from, to explore this basic question.
The first level of comparison we undertook was the mobility of
receptors. Due to the availability of the unique cell system with an
integrated array of the natural MMTV promoter containing
multiple HREs, it is possible to observe binding events by steroid
Figure 1. Distinct mobilities of GFP-AR and GFP-GR at the
MMTV array in living cells. (A) GFP-AR and GFP-GR expression in
3108 and 3617 cells, respectively. Cells were treated with agonists
R1881 or DEX as indicated. Total cell extracts were subjected to Western
analysis using an anti-GFP antibody (upper panels) and an anti-a-
tubulin antibody as loading control (lower panels). Relative quantifica-
tion of band intensities is indicated below the lanes; a-tubulin at each
time point was set to 1.0. (B, C) GFP-AR and GFP-GR show distinct FRAP
recovery dynamics at the MMTV array. 3108 cells (B) and 3617 cells (C)
were treated with agonists R1881 or DEX for the given time periods.
GFP fluorescence at the MMTV array was bleached and recovery after
bleaching was followed by live cell imaging. FRAP curves were
generated, and recovery half times were determined in a semi-
quantitiave manner. Error bars represent means 6 standard error.
doi:10.1371/journal.pone.0105204.g001
Figure 2. GFP-AR and GFP-GR differentially associate with and
activate transcription from the MMTV LTR. Time course of GFP-AR
(A) and GFP-GR (B) transcriptional activity and promoter occupancy at
the MMTV LTR. 3108 cells (AR) in (A) or 3617 cells (GR) in (B) were
treated with agonists R1881 or DEX for the given time points. MMTV-
Ras transcript levels were examined by qPCR (y-axis on the left-hand
side). ChIP analysis was performed using an anti-GFP antibody, and
receptor occupancy at MMTV LTR was determined by qPCR (y-axis on
the right-hand side). Error bars represent means 6 standard deviation.
doi:10.1371/journal.pone.0105204.g002
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Figure 3. Transcription complexes at the MMTV promoter are differentially sensitive to RNA Pol II inhibitors. (A) DRB and ActD inhibit
hormone induced Ras transcription in 3108 or 3617 cells. (B) DRB and ActD have differential effects on GFP-AR and GFP-GR mobility at MMTV LTR.
After treatment with agonist R1881 or DEX alone or in combination with inhibitors DRB or ActD, GFP-AR (3108 cells) and GFP-GR (3617 cells) bound to
the MMTV-LTR array were subjected to semi-quantitative FRAP analysis. The recovery half time values for ActD treatment were not determined (nd)
as the fluorescence recovery was not large enough during the experimental time period. Error bars represent means 6 standard error. (C) DRB and
ActD decrease GFP-AR and GFP-GR occupancy at the MMTV array. 3108 or 3617 cells were treated as in (A). qPCR was used to validate ChIP analysis
performed with an anti-GFP antibody using known binding sites at MMTV LTR. Error bars represent means 6 standard deviation. (D) DRB and ActD
have distinct effects on elongating Pol II at the MMTV array. 3108 or 3617 cells were treated as indicated in (A). qPCR was used to validate ChIP
analysis performed with an anti-Pol II-pSer2 antibody using known binding sites at MMTV promoter. Error bars represent means 6 standard
deviation.
doi:10.1371/journal.pone.0105204.g003
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receptors in living cells and study their dynamics [14,15,26]. Since
in previous studies the cell culturing conditions, length of
treatments, as well as the equipment for FRAP analysis were
different which can all affect the calculated recovery half times, we
compared the dynamics of GFP-AR and GFP-GR under the same
conditions using the same equipment. As shown in Figure 1B-C,
we found that GFP-GR had a faster fluorescence recovery curve
(i.e. short recovery half time) compared with that of GFP-AR.
Because GFP-AR and GFP-GR are similar in size, expression level
(Figure 1A), primary and tertiary structure of the DNA binding
domain [27,28], and their affinity towards the MMTV HREs
[29,30], the basis of this difference is not clear at present. One
possibility is that the two receptors bind different cofactors that
could affect the FRAP curve due to their binding affinity or
cooperative effects of whole complexes; however, there is no
known clear distinction in the cofactors that GR and AR interact
with when bound to the MMTV HRE. Another possibility is that
GFP-AR and GFP-GR binding to the HREs differentially affects
local chromatin structure or epigenetic marks which in turn could
alter recovery half times. Examination of global changes in
acetylation as well as some specific histone marks has not indicated
any differences in this regard (data not shown). A third possibility is
that during the activation process the receptors themselves could
differentially be modified posttranslationally which could affect
their function and/or binding kinetics. For example, AR has been
shown to be modified by phosphorylation, sumoylation, acetyla-
tion, or methylation events [31–34] at least some of which have
not been described for GR. Another possibility is differential
involvement of chaperone proteins, such as HSP90, or the
proteasome, since both of these are implicated in the regulation
of AR or GR dynamics and activity [19,35–37]. Further work is
needed to assess these possibilities.
Previous studies have shown that the kinetics of steroid receptor
action at different REs can be quite complex due to alternate
activation and repression phases. For example, microarray
profiling revealed at least 12 distinct modes of action for GR at
different HREs [38]. Thus, we asked whether GFP-AR and GFP-
GR have differences in the kinetics of transcription at the MMTV
HREs. GFP-AR mediated transcription increased gradually
reaching maximal levels by 8 h and was stable at least up to
12 h (Figure 2). In contrast, and consistent with previous work
(e.g. [39]), GFP-GR activated transcription rapidly, reaching
maximal levels by 2 h upon which levels declined rapidly. The
contrasting kinetic profiles suggest that the mode of action of the
two receptors at the MMTV HRE is different and that they would
give rise to distinct responses at this gene locus upon activation. At
present the precise mechanism underlying the differential dynamic
behaviour of the GFP-AR and GFP-GR at the MMTV promoter
is not known. The differences could derive from modification
status of the receptors or the promoter, the composition of the
associated coactivator/corepressor complexes, as well as promoter
structure and MMTV array size during the time-course of
transcriptional regulation.
To follow the promoter occupancy of GFP-AR and GFP-GR
during transcription activation at the MMTV array, we performed
ChIP analysis. The current model suggests that the occupancy and
residence times of a TF at a RE are not strictly correlated and can
be measured independently. Interestingly, studies with the yeast
TF, Rap1 indicates TF dynamics correlates more strongly than
occupancy with genomic function [40]. Thus, given that GFP-AR
has a slower FRAP curve (i.e. longer recovery half time) compared
with GFP-GR, the prediction was that GFP-AR ChIP signals at
the MMTV HRE should be higher than that for GFP-GR when
both receptors were activated. However, this was not the case; in
fact, GFP-GR ChIP signals, at the time at which FRAP
measurements were taken, were similar to that observed with
GFP-AR (Figure 2). This suggests that, at least in some cases, there
may be no direct correlation between the TF kinetics and
occupancy at REs.
There are several possibilities that can explain these results. One
possibility is that the frequency of interactions by GFP-GR at the
HRE among the whole cell population is higher compared with
GFP-AR and thus this can ‘compensate’ for faster fluorescence
recovery kinetics. This is possible since we did not observe any
changes in the fluorescence recovery curves at different times after
receptor activation when the transcription output was variable
(Figure 1B-C and Figure 2). In spite of the similar magnitude of
the ChIP signals at the time points with highest transcription, there
was a significant difference in the time course of GFP-AR and
GFP-GR association with the MMTV: whereas GFP-AR gradu-
ally reached its steady state loading levels by 1 h and did not
significantly change after that, GFP-GR also reached highest levels
at 1 h, but rapidly declined thereafter decreasing back to almost
basal levels by 12 h (Figure 2). At present we do not know the
reason for these differences. As in the recovery half time difference,
these observations could be due to differential posttranslational
changes to the receptor, its associated cofactors, or the chromatin
template.
To determine whether binding events of GFP-AR and GFP-GR
at the MMTV may require active transcription, we used
transcription inhibitors, DRB and ActD. Interestingly, although
not interfering with mobility of receptors, DRB significantly
decreased the levels of receptors bound to MMTV HREs. In
contrast, ActD significantly slowed down both GFP-AR and GFP-
GR FRAP curves and diminished occupancy (Figure 3B, 3C).
Recently, ActD was suggested to inhibit trafficking of GR to the
nucleus in mouse thymocytes [41]. However, microscopy exper-
iments did not show the same effect of ActD on GFP-AR and
GFP-GR. These data indicate that the gene regulation by the
promoter-associated GFP-AR and GFP-GR interacting with
cofactors and Pol II is regulated in a complex manner. The
observed differential dynamics of GFP-AR and GFP-GR at the
MMTV promoter during the time-course of transcriptional
activation may impact the transcription initiation complex. For
example, it is possible that promoter occupancy of GFP-AR and
GFP-GR may be linked to the transcription elongation process.
Indeed, it has been reported that positive transcription elongation
factor b (P-TEFb) interacts with AR and enhances efficiency of
transcription elongation [42]. In addition, large inactive P-TEFb
complex has been shown to be disrupted by ActD that was also
shown to inhibit interactions between TF and its binding site
[43,44]. Thus, the receptor association with HREs may be directly
related to elongation events.
The discrepancy between DRB and ActD effects on receptor
mobility and occupancy levels may also be explained by the
differential action of inhibitors on transcription elongation. DRB is
an inhibitor of Pol II-Ser2 phosphorylation and may per se not
interfere with receptor binding dynamics. In contrast, as ActD
intercalates to DNA, it might change the local chromatin structure
around the HRE and affect receptor-chromatin interactions.
Considering that ChIP analysis determines occupancy levels, ActD
may interfere with frequency of receptor-chromatin interactions as
a whole in the cell population without affecting receptor mobility
in single cells.
There was a decrease in Pol II-pSer2 levels at the MMTV array
in the presence of DRB in both GFP-AR and GFP-GR cells, as
expected. Interestingly, we have observed that Pol II is differen-
tially recruited to the MMTV array during a time course of
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transcription activation by GFP-AR and GFP-GR (data not
shown). This suggests that in case of activation by GFP-AR Pol II
might be poised at the transcription start site. On the other hand,
ActD decreased Pol II-pSer2 levels only in the presence of GFP-
GR. Since ActD was shown to promote accumulation of
phosphorylated Pol II-Ser2 [45], it may explain the binding of
Pol II-pSer2 in the presence of GFP-AR. However, it is clear that
ActD affects transcription at different levels with a decrease in
transcriptional outcome. These data suggest that the ‘communi-
cation’ between the two receptors and the transcription machinery
may be differentially achieved.
The precise molecular basis for the striking differences between
GFP-AR and GFP-GR activity bound at the same HRE are
currently not clear. Previous studies have suggested that amino
acid differences in the steroid receptors might contribute to altered
transcriptional outcomes at the same HRE [29,46,47]; however,
most of this previous work was conducted using reporter plasmids
and transient transfection assays and did not provide any
mechanistic explanation. It has also been reported that binding
to non-conventional HRE sequences might lead to differences in
receptor activity, or that non-receptor factors are involved in
further regulating specificity of steroid receptor functions acting at
the same HRE [48,49]. Regardless of the mechanism, the data we
have presented suggest that the dynamics and presentation of the
two receptors bound at the HREs to the transcriptional initiation
machinery and the RNA Pol II complex are distinctly different
which may affect the FRAP curves and promoter binding kinetics;
this, in turn, is likely to engage the basal transcription apparatus
differently in response to extracellular stimuli. Thus, even though
every gene may have a set transcription regulation program, this
can be orchestrated differently by related but distinct TFs bound at
the same REs through distinct mechanisms.
Supporting Information
Figure S1 GFP-AR induced transcription from the
MMTV array. 3108 cells (GFP-AR) were left either untreated
or treated with R1881 for the given time points. RNA FISH
analysis was performed on fixed cells. The FISH signals were
detected by confocal microscopy and quantified from .110
randomly chosen cells for each time point. Error bars represent
means 6 standard error.
(TIF)
Method S1 Supplemental Method including Supplemen-
tal Literature.
(DOC)
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